29 results on '"Guilleminot, Tiffany"'
Search Results
2. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
3. Predictors of the Outcome at 2 Years in Neonates With Congenital Cytomegalovirus Infection
4. Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva
5. Clinical Value of Serial Quantitative Analysis of Cytomegalovirus DNA in Blood and Saliva Over the First 24 Months of Life in Congenital Infection: The French Cymepedia Cohort
6. Third trimester placentitis: an underreported complication of SARS-CoV-2 infection
7. Cytokine Profiling of Amniotic Fluid from Congenital Cytomegalovirus Infection
8. Saliva for molecular detection of SARS‐CoV‐2 in pre‐school and school‐age children
9. Detection of cytomegalovirus DNA on dried blood spots collected from infants infected with HIV: An in-house method adaptable in resource-limited settings
10. Performance of Targeted Congenital Cytomegalovirus Screening in Newborns Failing Universal Hearing Screening: A Multicenter Study
11. Prospective Identification of Congenital Cytomegalovirus Infection in Newborns Using Real-Time Polymerase Chain Reaction Assays in Dried Blood Spots
12. Une infection antérieure par des coronavirus saisonniers n’empêche pas la COVID-19 chez les enfants
13. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study
14. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis
15. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020
16. Congenital Cytomegalovirus Is the Second Most Frequent Cause of Bilateral Hearing Loss in Young French Children
17. Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children
18. Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection
19. Adaptive and Innate Immune Cells in Fetal Human Cytomegalovirus-Infected Brains
20. Evaluation of 31 Commercial SARS-CoV-2 Serology Assays
21. Quantifying the Burden of Congenital Cytomegalovirus Infection With Long-term Sequelae in Subsequent Pregnancies of Women Seronegative at Their First Pregnancy
22. Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy
23. Quantifying the Burden of Congenital Cytomegalovirus Infection With Long-term Sequelae in Subsequent Pregnancies of Women Seronegative at Their First Pregnancy.
24. Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy.
25. Long-Term Sequelae of Congenital Cytomegalovirus Infection are Limited to Maternal Infection in the First Trimester of Pregnancy
26. Comparison of the LIAISON ® CMV IgG Avidity II and the VIDAS ® CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women
27. Congenital Cytomegalovirus Is the Second Most Frequent Cause of Bilateral Hearing Loss in Young French Children
28. Comparison of the LIAISON® CMV IgG Avidity II and the VIDAS® CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women.
29. In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.